What the COVID-19 Stimulus Package Offers Patients & Providers

Newly signed into law, the Coronavirus Aid, Relief, and Economic Security (CARES) Act is a $2 trillion aid package aimed at shoring up America’s health care system and providing relief to those harmed by the ongoing COVID-19 pandemic.
Heart Patients, Keep Trying
New medications are expanding the toolbox for health care providers like me to treat patients with high cholesterol. That gives more than 100 million at-risk Americans a better shot at effective, patient-centered care.
Capping Insulin Co-pays Could Help Fight COVID-19

I have been a doctor for 35 years and I have seen a lot of crises. But I have never seen the country’s health care resources strained the way they are right now.
Clinical Trials in the Time of Coronavirus

The COVID-19 outbreak has triggered new rounds of clinical trials to identify treatments for the coronavirus.
Dry Eye Disease Deserves Patient-Centered Care

The verdict is in: personalized, patient-centered care is better care. That’s especially true when it comes to dry eye disease.
What COVID-19 Means for Surprise Billing

The last thing anyone impacted by COVID-19 needs is an unexpected medical bill. Yet health insurance industry experts say that likely will happen to some patients.
For Preemie Parents, COVID-19 Anxiety Feels Familiar
A bottle of Purell sits on a table inside my front door. If I had guests, I would ask them to use it.
Diagnosis and Treatment Challenges Strain Amyloidosis Patients

All patients have a story about how they began experiencing symptoms, saw their doctor and came to a diagnosis.
ICER Misses the Numbers That Matter

The Institute for Clinical and Economic Review wants to assess the cost-effectiveness of breakthrough drugs for cystic fibrosis. But their analysis overlooks key points. View the Graphic
Uniting in the Fight against Brain Illness

The number of people with Parkinson’s disease doubled from 1990 to 2015 – and is expected to double again over the next 20 years. The disease’s growing prevalence underscores why increased awareness and research for brain illness remain critical.